Arcturus Therapeutics Holdings Inc (NAS:ARCT)
$ 18.36 -0.47 (-2.5%) Market Cap: 497.32 Mil Enterprise Value: 302.30 Mil PE Ratio: 0 PB Ratio: 1.90 GF Score: 76/100

Q2 2024 Arcturus Therapeutics Holdings Inc Earnings Call Transcript

Aug 05, 2024 / 08:30PM GMT
Release Date Price: $19.79 (-3.70%)
Operator

Greetings and welcome to Arcturus Therapeutics second quarter 2024 earnings call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Neda Safarzadeh, Vice President, Head of Investor Relations, Public Relations and Marketing. Thank you, Neda. You may begin.

Neda Safarzadeh Arcturus Therapeutics Holdings Inc;VP
Head of IR, Public Relations and Marketing

Thank you, operator. Good afternoon and welcome to Arcturus fluidics, quarterly financial update and pipeline progress call. Today's call will be led by Joe Payne, our President and CEO; and Andy Sassine, our CFO; Dr. Pad Chivukula, our CSO and COO, will join them for the Q&A session.

Before we begin, I would like to remind everyone that statements made during this call regarding matters that are not historical facts are forward-looking statements within the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of performance.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot